JDD

JDD March 2024 Issue Highlights
alopeciaMarch into groundbreaking dermatological insights with the latest issue of the Journal of Drugs in Dermatology! Explore the prescribing habits of oral minoxidil for androgenetic alopecia, delve into a comprehensive review of botulinum toxin uses, and discover the effectiveness of microneedling for acne scars. Plus, unravel the uncertainties surrounding exosome therapy in androgenetic alopecia. Fro …
alopecia
JDD February 2024 Issue Highlights
psoriasisExplore the February 2024 issue of the Journal of Drugs in Dermatology! Discover groundbreaking research on topics such as novel treatments for melasma, advancements in psoriasis management, gene expression profile (GEP) testing for squamous cell carcinoma, pediatric vitiligo, and many more! Stay ahead of the curve with the latest insights from leading dermatology experts. Straight from the Editor …
psoriasis
JDD Buzz Series: Oral Minoxidil Shortages After Media Attention
MINOXIDILMedia attention about oral minoxidil has impacted access to the hair loss drug in the Washington, D.C. area, according to a study published in the January issue of the Journal of Drugs in Dermatology. Researchers found shortages of the drug in D.C.-area pharmacies more than a year after an article about the treatment appeared in The New York Times. To find out more about oral minoxidil access, …
MINOXIDIL
JDD January 2024 Issue Highlights
Journal of Drugs in DermatologyThe Journal of Drugs in Dermatology welcomes 2024 with a strong line up of original articles, case reports, brief communications, and letters to the editor. Straight from the Editor's desk, we share this month's issue highlights! ORIGINAL ARTICLES Current Landscape of Hyaluronic Acid Filler Use in the United States shares the results of a comprehensive search of all the FDA approved dermal fill …
Journal of Drugs in Dermatology
Author Q&A: YouTube Videos on Topical Steroid Withdrawal
topical steroid withdrawalThe 10 most viewed YouTube videos on topical steroid withdrawal (TSW) overall had low reliability and quality, according to a study published in the November issue of the Journal of Drugs in Dermatology. The authors recommend dermatologists provide alternate, evidence-based resources for their patients, both in clinical practice and online, including YouTube. To find out more about the quality …
topical steroid withdrawal